National Heart, Lung, and Blood Institute - Research Centers
Active
- Assistance listing
- 93.HL6
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-0872-0-1-552
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) funds research centers aligned with prevention and treatment of heart, lung, blood, and sleep conditions under Assistance Listing 93.HL6, with regular grants taking 7 to 9 months from application acceptance to award preparation.
The program supports research centers—including renewal applications reviewed alongside new submissions—that advance NHLBI's mission in cardiovascular, pulmonary, hematologic, and sleep medicine research. Evaluation criteria emphasize scientific merit and significance, technical adequacy of experimental design, investigator competency, facility and resource adequacy, budget justification relative to project scope, and relevance to announced program objectives. All applications undergo initial review by an appropriate study section, followed by secondary review and recommendation by the National Heart, Lung, and Blood Advisory Council before award preparation begins.
Eligible applicants include state and local governments (including state-designated Indian Tribes), public and private nonprofit institutions and organizations (encompassing institutions of higher education and hospitals), individuals and families, small businesses with fewer than 500 employees, and for-profit companies engaged in biomedical research. Any nonprofit organization or for-profit entity pursuing biomedical research may apply; approval requires demonstrated scientific merit and program relevance by peer review.
Grantees must retain financial, programmatic, and statistical records for three years from the date of the annual Financial Status Report submission (with exceptions for active litigation, claims, or audit). Recipients expending $750,000 or more in federal awards annually are subject to single or program-specific audit under 2 CFR 200, Subpart F; those expending less than $750,000 annually are exempt except as noted in 2 CFR 200.503. The HHS Inspector General and U.S. Comptroller General retain rights of timely and unrestricted access to recipient records pertinent to awards.
The source provides no recent grant awards, recent grant opportunities, or portfolio data on award volume, funding concentration, or typical award magnitudes.
Objective and description
- Objective
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep conditions and enhance the health of all individ
- Description
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, blood, and sleep conditions and enhance the health of all individuals so that they can live longer and more fulfilling lives. NHLBI supports research centers that align with fulfilling the mission of the NHLBI.
Eligibility
- Applicant eligibility
Local (includes State-designated Indian Tribes; excludes institutions of higher education and hospitals), Public nonprofit institution/organization (includes institutions of higher education and hospitals), Individual/Family, Small business (less than 500 employees), Private nonprofit institution/organization (includes institutions of higher education and hospitals). Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
- Beneficiary eligibility
Any nonprofit or for-profit organization, company or institution engaged in biomedical research.
- Uses of assistance
Grants may support stipends, research expenses, supplies, travel, childcare costs, and research training tuition as required to perform the research effort.
- Use restrictions
Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research.
How to apply
- Criteria for selecting proposals
The major elements in evaluating proposals include assessments of: (1) the scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives.
- Award procedure
All accepted applications are evaluated by an appropriate initial review group (study section). All grant applications receive a final secondary review by the National Heart, Lung, and Blood Advisory Council. Staff inform applicants of the results of the review. If support is contemplated, staff initiate preparation of awards for grants.
- Time to approval or disapproval
Regular Grants: From 7 to 9 months.
- Renewals
Renewal applications are reviewed in the same manner as new applications.
- Appeals
A principal investigator (P.I.) may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available in the NIH Guide at the following URL http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.
Grant opportunities
| Opportunity | Status | Posted | Applications due |
|---|---|---|---|
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Trial Required) | Open | ||
| HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required) | Open |
Quick answers
What is Assistance Listing 93.HL6?
Assistance Listing 93.HL6 is National Heart, Lung, and Blood Institute - Research Centers, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for National Heart, Lung, and Blood Institute - Research Centers?
Its CFDA number is 93.HL6: Assistance Listing numbers were called CFDA numbers before 2018.
Are there open grant opportunities under 93.HL6?
2 listed opportunities under 93.HL6 are open or forecasted. The latest, HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Trial Required), was posted on April 8, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program